Sonoma Pharmaceuticals Stock Alpha and Beta Analysis
| SNOA Stock | USD 0.17 0.01 6.25% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Sonoma Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Sonoma Pharmaceuticals over a specified time horizon. Remember, high Sonoma Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Sonoma Pharmaceuticals' market risk premium analysis include:
Beta (1.32) | Alpha (0.19) | Risk 6.16 | Sharpe Ratio 0.0298 | Expected Return 0.18 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Sonoma |
Sonoma Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Sonoma Pharmaceuticals market risk premium is the additional return an investor will receive from holding Sonoma Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sonoma Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Sonoma Pharmaceuticals' performance over market.| α | -0.19 | β | -1.32 |
Sonoma Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Sonoma Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Sonoma Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Sonoma Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Sonoma Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sonoma Pharmaceuticals shares will generate the highest return on investment. By understating and applying Sonoma Pharmaceuticals stock market price indicators, traders can identify Sonoma Pharmaceuticals position entry and exit signals to maximize returns.
Sonoma Pharmaceuticals Return and Market Media
The median price of Sonoma Pharmaceuticals for the period between Thu, Jan 18, 2024 and Wed, Apr 17, 2024 is 0.16 with a coefficient of variation of 9.85. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 0.16, and mean deviation of 0.01. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Animal Wound Care Market Poised for Growth North America Leads, Innovations and Veterinary Spending Surge | 01/29/2024 |
2 | Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results | 02/08/2024 |
3 | Sonoma Pharmaceuticals, Inc. Short Interest Down 21.2 percent in February - Defense World | 03/04/2024 |
4 | The end of Hackintosh how Apple is sounding the death knell for a once-thriving online community | 03/18/2024 |
5 | Sonoma Pharmaceuticals, Inc. Revenue Breakdown NASDAQSNOA TradingView - TradingView | 03/28/2024 |
6 | Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States | 04/09/2024 |
7 | macOS 14 Sonoma Release date, features, Mac compatibility | 04/15/2024 |
About Sonoma Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Sonoma or other stocks. Alpha measures the amount that position in Sonoma Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.35 | 0.36 | Price To Sales Ratio | 0.29 | 0.27 |
Sonoma Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Sonoma Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sonoma Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Sonoma Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Sonoma Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Sonoma Pharmaceuticals' management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 19th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 19th of June 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Sonoma Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Sonoma Pharmaceuticals Backtesting, Sonoma Pharmaceuticals Valuation, Sonoma Pharmaceuticals Correlation, Sonoma Pharmaceuticals Hype Analysis, Sonoma Pharmaceuticals Volatility, Sonoma Pharmaceuticals History and analyze Sonoma Pharmaceuticals Performance. For information on how to trade Sonoma Stock refer to our How to Trade Sonoma Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Sonoma Stock analysis
When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Sonoma Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.